SCHEMBL21135648

SCHEMBL21135648

CCC(C)c1cc(Cl)cc(OC)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.40
GAA P10253 3/20 0.40
MAPT P10636 3/20 0.40
ABCB11 O95342 1/20 0.38
NPBWR1 P48145 1/20 0.36
MCHR1 Q99705 1/20 0.36
HPGD P15428 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
AHR P35869 1/20 0.33
CRHR1 P34998 1/20 0.33
TSHR P16473 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
POLB P06746 1/20 0.33
KMT2A Q03164 1/20 0.33
CASR P41180 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
ALOX12 P18054 1/20 0.33
USP2 O75604 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10138510 0.86 ALDH1A1 (0.50) ALDH1A1GAAMAPTABCB11HPGD
SCHEMBL18948438 0.86 ABCB11 (0.36) ALDH1A1ABCB11AHRCASR
SCHEMBL17071843 0.82 TSHR (0.40) ALDH1A1GAAHPGDTSHRMEN1
SCHEMBL10289777 0.82 TSHR (0.40) ALDH1A1GAAHPGDTSHRMEN1
SCHEMBL7644300 0.82 TSHR (0.40) ALDH1A1GAAHPGDTSHRMEN1
SCHEMBL9178609 0.82 ALDH1A1 (0.39) ALDH1A1GAAMAPTHPGDTSHR
SCHEMBL2737289 0.80 ALDH1A1 (0.42) ALDH1A1ABCB11NPBWR1MCHR1AHR
SCHEMBL24117056 0.80 DDR1 (0.36) ALDH1A1TSHR
SCHEMBL2758520 0.79 ALDH1A1 (0.41) ALDH1A1GAAMAPTABCB11HPGD
SCHEMBL19275144 0.78 ALDH1A1 (0.40) ALDH1A1GAAMAPTABCB11HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10336748-B2 Methyoxy-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof PFIZER INC. (US) 2019-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10336748-B2 Methyoxy-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof RORC, RORB, RORA ALDH1A1 484/4885GAA 1994/4885MAPT 3937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.